[Skip to Navigation]
Sign In
Viewpoint
July 25, 2017

Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration

Author Affiliations
  • 1Department of Medicine, Division of Cardiology, University of California, San Francisco
  • 2Editor of JAMA Internal Medicine
  • 3Department of Obstretrics and Gynecology, University of California, San Francisco
  • 4Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
JAMA. 2017;318(4):325-326. doi:10.1001/jama.2017.7704
Add or change institution
×